newsfilter
← Latest News
PR Newswire·

Valeo Pharma Projecting Record Revenues for Second Quarter 2021

Record revenues and margins expected for Q2-21 Redesca® launch beginning to impact financial performance Respiratory sales force infrastructure well advanced in support of coming Enerzair® Breezhaler® and Atectura® Breezhaler® commercial